Trasylol - Bayer stops sales of Trasylol.
NEWS Update: February 19, 2008.
60 Minutes does show on Bayer Drug Trasylol.
A renowned medical researcher estimates that 22,000 patients could have been saved if the Food and Drug Administration removed the heart surgery drug Trasylol two years ago.
In a scathing documentary the television show 60 Minutes tells of one researcher’s findings on the Bayer drug Trasylol.
Featured in the TV show is San Francisco medical researcher, Dr. Dennis Mangano who studied the drug use in 5,065 patients in 17 countries. His studies indicated that patients that were given Trasylol had a greater risk for renal (kidney) failure and other complications.
"It showed an important association between Trasylol use and kidney failure requiring dialysis, Mangano tells Pelley, “And it showed a trend toward increased death in hospital in these patients."
The story goes on to illustrate that Bayer had known the drug was unsafe and did not halt sales. The story also talks about the current role the FDA has in testing these drugs.
November 5, 2007: Trasylol FDA NEWS:
Bayer AG will stop all sales on its antibleeding drug Trasylol in the U.S. market due to expanding evidence that it may be linked to a higher risk of death than that of other drugs.
Trasylol was manufactured to help reduce or prevent blood loss during complicated procedures such as cardiac surgery. Excessive bleeding is a common and dangerous complication after major surgeries, and Trasylol reduces the likelihood of potentially life-threatening hemorrhaging. Blood loss is always dangerous, but after surgeries such as coronary artery bypasses it can be immediately fatal.
Unfortunately, according to a study of 4,374 coronary bypass artery patients published in the January 25 issue of the New England Journal of Medicine, Trasylol doubles the risk of renal failure and stroke and also increases the risk of heart failure or heart attack by 55%. Doctors continue to struggle with the complications of Trasylol, and are beginning to turn to generic drugs that provide the same benefits.
The Food and Drug Administration issued an advisory on February 9, 2006 to alert doctors to limit the use of Trasylol in patients during coronary artery bypass surgery due to the risk of potentially-fatal kidney trauma. There are a number of less expensive and dangerous generic drugs that could prevent renal failure in 9,000 to 11,000, but Bayer AG maintains that the findings of the FDA and the NEJM do not reflect the 15 years of data collected from their own studies.
If you or someone you love was injured by the severe side effects of Trasylol, you may be entitled to pursue financial compensation for your pain and suffering, but if you wait too long laws called statutes of limitations could prevent you from pressing your case. Let a dedicated and experienced defective drug attorney help you get you the restitution you deserve. Contact a Trasylol lawyer today.
Other Defective Drug Topics
- Accutane
- ACE Inhibitors
- Ambien
- Anesthetic Creams
- Aranesp
- Aredia
- Avandia
- Bayer Diabetes Care Contour Test Strips
- Botox
- Carbamazepine
- Cefepime
- Celebrex
- Cialis
- Children's Cough and Cold Medication
- Colchicine
- Crestor
- Cytotec
- Depakote
- Dietary Supplements
- Dostinex
- Ephedra
- Epogen
- Femara
Begin your case review by filling out the form below or call us 24 hours a day, 7 days a week at
1-888-775-3779
Fill out our free case review form including all contact information and as many details about your case as possible.
Relax. Our qualified legal staff is reviewing your case information.
You will be contacted by a member of our legal staff within 24 hours of submitting your information. They will review your case details with you and walk you through the rest of the legal process.
Partnerships and Trial Lawyer Associations - Lawyers in our law firm and lawyers in our affiliated law firms
are proud members of many organizations and associations dedicated to seeking justice for the American people.
Send to a Friend
Print This Page
Add to Favorites